- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.29 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x JT3: [(~{E})-2-[2-[(4-oxidanylidene-3,5-dihydropyrrolo[3,2-d]pyrimidin-7-yl)sulfanyl]-6-[2,3,4,5,6-pentakis(fluoranyl)phenoxy]phenyl]ethenyl]phosphonic acid(Non-covalent)
- 9 x TEW: 6-tungstotellurate(VI)(Non-covalent)
TEW.2: 6 residues within 4Å:- Chain A: Y.5, N.55, F.56, P.57, R.58, K.95
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:Y.5, A:Y.5, A:R.58, A:K.95, A:K.95
TEW.3: 5 residues within 4Å:- Chain A: R.207, D.248, Y.249, E.250
- Chain B: R.133
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:R.207, A:R.207, A:Y.249, A:E.250, B:R.133, B:R.133
TEW.4: 9 residues within 4Å:- Chain A: P.92, W.94, Q.144, R.148
- Chain C: G.90, P.92, Q.144
- Ligands: TEW.9, TEW.14
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: A:Q.144, A:R.148, A:R.148, C:G.90, C:Q.144
TEW.7: 6 residues within 4Å:- Chain B: Y.5, N.55, F.56, P.57, R.58, K.95
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:Y.5, B:Y.5, B:R.58, B:K.95, B:K.95
TEW.8: 5 residues within 4Å:- Chain B: R.207, D.248, Y.249, E.250
- Chain C: R.133
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain C- Hydrogen bonds: B:R.207, B:R.207, B:Y.249, B:E.250, C:R.133, C:R.133
TEW.9: 9 residues within 4Å:- Chain A: G.90, P.92, Q.144
- Chain B: P.92, W.94, Q.144, R.148
- Ligands: TEW.4, TEW.14
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:Q.144, B:R.148, B:R.148, A:G.90, A:Q.144
TEW.12: 6 residues within 4Å:- Chain C: Y.5, N.55, F.56, P.57, R.58, K.95
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:Y.5, C:Y.5, C:R.58, C:K.95, C:K.95
TEW.13: 5 residues within 4Å:- Chain A: R.133
- Chain C: R.207, D.248, Y.249, E.250
6 PLIP interactions:4 interactions with chain C, 2 interactions with chain A- Hydrogen bonds: C:R.207, C:R.207, C:Y.249, C:E.250, A:R.133, A:R.133
TEW.14: 9 residues within 4Å:- Chain B: G.90, P.92, Q.144
- Chain C: P.92, W.94, Q.144, R.148
- Ligands: TEW.4, TEW.9
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain C- Hydrogen bonds: B:G.90, B:Q.144, C:Q.144, C:R.148, C:R.148
- 3 x NA: SODIUM ION(Non-functional Binders)
NA.5: 2 residues within 4Å:- Chain A: T.6, E.8
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:T.6, A:T.6
NA.10: 2 residues within 4Å:- Chain B: T.6, E.8
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:T.6, B:E.8
NA.15: 2 residues within 4Å:- Chain C: T.6, E.8
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:T.6, C:T.6
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Skacel, J. et al., Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine Nucleoside Phosphorylase Inhibitors. J.Med.Chem. (2023)
- Release Date
- 2023-05-17
- Peptides
- Purine nucleoside phosphorylase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.29 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x JT3: [(~{E})-2-[2-[(4-oxidanylidene-3,5-dihydropyrrolo[3,2-d]pyrimidin-7-yl)sulfanyl]-6-[2,3,4,5,6-pentakis(fluoranyl)phenoxy]phenyl]ethenyl]phosphonic acid(Non-covalent)
- 9 x TEW: 6-tungstotellurate(VI)(Non-covalent)
- 3 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Skacel, J. et al., Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine Nucleoside Phosphorylase Inhibitors. J.Med.Chem. (2023)
- Release Date
- 2023-05-17
- Peptides
- Purine nucleoside phosphorylase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A